Table 3.
Low cognitive function assessed by CERAD test | Low cognitive function assessed by Animal Fluency Test |
Low cognitive function assessed by DSST |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Crude | Model 1 | Model 2 | Crude | Model 1 | Model 2 | Crude | Model 1 | Model 2 | |||
TyG index (continuous) | 1.43 (1.00, 2.04) * | 1.50 (0.99, 2.66) | 1.61 (1.01, 2.57) * | 1.06 (0.68, 1.63) | 1.05 (0.68, 1.63) | 1.29 (0.71, 2.36) | 0.84 (0.57, 1.24) | 0.80 (0.52, 1.22) | 0.88 (0.46, 1.67) | ||
TyG index (quartiles) | |||||||||||
Q1 | Reference | Reference | Reference | ||||||||
Q2 | 1.11 (0.61, 2.00) | 1.05 (0.58, 1.89) | 0.95 (0.49, 1.82) | 1.04 (0.60, 1.79) | 1.01 (0.62, 1.66) | 1.05 (0.52, 2.10) | 0.97 (0.54, 1.37) | 0.90 (0.48, 1.67) | 0.81 (0.30, 2.16) | ||
Q3 | 1.43 (0.77, 2.64) | 1.27 (0.63, 2.55) | 1.20 (0.57, 2.50) | 1.30 (0.74, 2.28) | 1.21 (0.71, 2.05) | 1.32 (0.73, 2.37) | 1.34 (0.68, 2.65) | 1.18 (0.61, 2.29) | 1.21 (0.51, 2.85) | ||
Q4 | 2.02 (1.12, 3.66) * | 2.20 (1.14, 4.26) * | 2.62 (1.31, 5.23) * | 0.97 (0.49, 1.91) | 0.94 (0.48, 1.83) | 1.21 (0.49, 3.01) | 0.68 (0.35, 1.32) | 0.64 (0.32, 1.29) | 0.76 (0.29, 1.99) |
Abbreviations: The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD); Digit Symbol Substitution Test (DSST)
Data are presented as OR (95% confidence intervals). * P < 0.05. ** P < 0.01
Crude model adjusted for None; Model 1 adjusted for age and gender; Model 2 adjusted for age, gender, BMI, race/ethnicity, educational level, family income-poverty
ratio, serum total cholesterol (mg/dl), physical activity, drinking status, smoking status, hypertension, heart failure, coronary heart disease, and stroke
The CERAD test included CERAD-WL and CERAD-DR.
Low cognitive function was defined the 25th quantile of each cognitive test score of each test as the cutoff point (CERAD: 23; AFT: 15; DSST: 43)